The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mallikarjun Rao Basaboini
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd disclosed a Regulation 29(1) SAST filing made by Mallikarjun Rao Basaboini together with three persons acting in concert (Basaboini Malathi, Mrinalini Basaboini, Mriganayani Basaboini – likely family members). None of them belong to the promoter or promoter group. On July 18, 2025, they were collectively allotted 15,00,000 equity shares (representing 6.56% of the expanded share capital) through a preferential allotment on a cash basis. The breakdown is 5 lakh shares each to Basaboini Malathi and Mallikarjun Rao Basaboini (2.19% each) and 2.5 lakh shares each to Mrinalini and Mriganayani Basaboini (1.09% each). Before this acquisition, the group held zero shares. As a result of the preferential issue, the company's total equity share capital expanded from 1,48,08,706 shares to 2,28,49,710 shares of Rs. 10 each.
Existing shareholders face dilution as the equity base grew by about 54% via a cash preferential allotment to non-promoter acquirers who have crossed the 5% disclosure threshold. The acquirer group's 6.56% stake puts them close to the next 10% SAST disclosure trigger, meaning further buying could attract additional regulatory scrutiny.